NewCleo
Founded in 2021, it is based in London, UK, and employs around 230 people. It’s a leader in the industry sector of nuclear energy.
What is NewCleo?
Newcleo offers a safe circular solution in Gen-IV nuclear, combined with an advanced, mature reactor technology that meets the rising demand for electricity and addresses the challenges of decarbonization and energy security. The result of over 25 years of research, NewCleo is building a new competitive standard in nuclear energy by using existing, accessible technology in innovative ways.
What is the NewCleo opportunity?
Reactor technology: LFR
Considered the most advanced and mature fast reactor technology
by GIF (Gen-IV International Forum)
Design built on a small modular reactor (SMR) concept.
Fuel: MOX 1
Newcleo reactors are fueled by MOX, which is obtained from the
Waste of the current nuclear waste-to-energy solution industry, creating an innovative nuclear
The solution that Newcleo is working on appears to be:
Safe: Patented lead-cooled technology benefits from a natural radiation shield and passive safety features
Carbon-free: zero-carbon baseload dispatchable generation to balance growing renewable intermittency
Circular: A unique newcleo solution for waste-as-a-fuel, eliminating the need for further uranium mining and enrichment and significantly reducing long-lived waste.
Affordable: The design benefits from modularity, portability (dispatchable), and standardization.
What is NewCleo's biggest strength?
Stefano Buono CEO and Chairman: A nuclear physicist who worked for ten years with physics Nobel laureate Carlo Rubbia at CERN and CRS4 in the field of accelerator-driven systems and atomic waste transmutation
In 2002, he founded Advanced Accelerator Applications, listed on NASDAQ (AAAP) from 2015 until its acquisition by Novartis for $3.9 billion.
For more coverage about Newcleo, subscribe to our club letter
NewCleo valuation
As of May 2024, Newcleo had already raised €526.6 million across three funding rounds, with significant investments from various international investors
NewCleo stock
NewCleo stock price source: IPO CLUB Valuation at Market©
Become a member for in-depth coverage of newcleo
NewCleo IPO
As of June 2024, NewCleo is a private company building the Brasimone precursor non-nuclear reactor for testing. The company is also already working on its LFR-AS-301 FOAK design, licensing, and construction, which will be delivered to France. The company expects to start working on its LFR-AS-301 FOAK design, licensing, and construction in 2024 for delivery to the U.K.
Latest news
Aug 23: NewCleo’s industrial strategy
Stay up-to-date with all the latest news pertaining to NewCleo stock, IPOs, and investment opportunities. By clicking here, you'll gain access to real-time updates and in-depth analysis from market experts, empowering you to make informed decisions about your investment journey. Whether you're a seasoned investor or just getting started, our platform is tailored to provide you with all the crucial information you need to navigate the thrilling world of the stock market and IPOs. Dive in and keep your finger on the pulse of the financial markets.
Introducing NewCleo
NewCleo stands at the forefront of nuclear energy, crafting the future of electricity generation. With a keen focus on acquiring and organically integrating all parts of reactor manufacture, they're pioneering LFR and Gen-IV reactors using spent nuclear fuel. As they approach the construction of their first non-nuclear, testing reactor, NewCleo is poised to revolutionize the nuclear power industry, merging cutting-edge generation technology with unparalleled recycling and circular economy solutions. This disruptive entity is set to reshape global energy, providing greener, more reliable electricity generation for western countries, cutting dependence on fossil fuels, and contributing to the western world’s energy security.
